Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Transplants + VTD in Multiple Myeloma
NCT00574080Phase 3Terminated
- Sponsor
- University of Arkansas
- Start
- Jul 2006
- Primary completion
- Mar 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib, thalidomide in multiple myeloma (MM), sponsored by University of Arkansas. Started Jul 2006; status: terminated.
02
Drugs
bortezomibthalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00574080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574080.